| 标题 |
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The lancet. Diabetes & endocrinology 作者:He Y; Mi N; Cheng Z; Xue H; Han J; et al 出版日期:2025/10/01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)